price month
 close
guidanc call ep rang slightli
estim consensu includ headwind fx
tariff well like conservat
hearten core organ sale growth target line
estim despit challeng comp lower ep
estim better reflect aforement headwind
sustain strength base busi dental spin track
target core revenu growth driven growth
across busi unit except dental help increas contribut
consum vs continu innov
life scienc greater exposur china dd compound-annual-growth-rate sinc
high growth applic billion biolog million
genom support healthi growth beyond
diagnost cepheid continu deliv dd core growth robust
continu innov digit offer custom sticki
dental spin remain track outlin longer term path
acceler growth flat/ lsd driven innov na end-market
stabil commerci execut continu target bp
annual oper margin expans dental
highlight firepow follow rel quiet year net
debt ttm ebitda view step acquisit activ
immin refer gross leverag reach
acquisit pall impli billion debt capac today excl pend
dental spin prodigi free cash flow gener driven continu
oper margin expans bp annual core margin work
capit improv ampl dri power redeploy capit
 target compani pipelin bias toward
busi lever resili lt healthcar driver gdp market
potenti focus consum risk slowdown util
macro condit unfavor regulatori shift miscu
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
lead manufactur system instrument
consum broad array purpos custom
diagnost dental environment health/appli scienc
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
acceler key end market global signific rebound
dental trend better expect implement db
acquir compani market share gain materi margin
grey sky scenario base signific weak
key end market prolong weak dental demand trend
deceler core growth acquisit integr headwind
 close
unveil initi outlook call ep rang
consensu previou estim includ headwind
fx million neg impact revenu fall-through
tariff like includ element conservat well
expect core sale growth line estim support broad-
base strength across non-dent platform new product launch
exposur high growth geographi end-market also gave estim season
ep emphas tougher
comp follow outsiz cepheid strength last year flu chang
ep guidanc
figur guidanc metric vs cs consensu
million except per share data
mid point
contribut
fall-
manag highlight impress track record msd core revenu growth
bp annual oper margin expans free cash flow-to-net incom
convers consecut quarter achiev feat driven db tool
emphas innov dilig cost structur initi
sustain strength organ revenu growth
expect core organ revenu growth line estim
ahead last year initi guid despit challeng year-
over-year comparison driven sustain strength across non-dent unit note core
compound-annual-growth-rate gener million annual revenu acquir april well
softwar million revenu lap juli deal closur
approxim revenu stem consum
previou transact strengthen exposur
consum recent propel dynam amongst
consider expect consum servic mix remain area focu
futur acquisit target effort help support higher margin recur
revenu stream cement longer term sticki custom relationship
highlight consum exposur notabl acquisit recent year
figur consumables/recur revenu stream
enhanc process driven increas product launch effici across
major platform particular beckman life scienc leica microsystem pall
cepheid videojet recent innov effort commerci invest
help drive meaning market share growth
launch three time product vs
doubl amount revenu new product
launch new hematolog analyz autom capabl new test menu item digit workflow solut
doubl number project on-tim market sinc acquisit launch genexpert edg clia-waiv xpert
test flu strep
new product launch sinc acquisit spend annual sinc
spark clear align launch australia us clearanc receiv oct
improv project on-time-to-market sinc
launch claro digit workflow solut increas new address market million
reduct time-to-market new product sinc
present potenti area
convers capit deploy option focu
view remain top prioriti capit deploy littl
disclos
emphas balanc sheet reflect lowest leverag level sinc
acquisit pall addit continu growth free cash flow gener see figur
help pay debt incur smaller deal billion
close april quickli importantli mark consecut
year free cash flow convers excess net incom support consist
oper leverag bp core margin expans annual well work
capit improv perform metric also tie execut compens
although manag provid littl detail area potenti interest relat
 note previou commentari highlight busi lever resili
lt healthcar driver gdp market focu consum vs inher
lumpi capit equip view quiet year front would
expect step acquisit activ near term
pall acquir
compani data credit suiss estim million
highlight key topic theme busi segment
life scienc revenu
life scienc segment current gener billion revenu repres
estim billion market adjust ebitda margin evolut
life scienc research increas chronic diseas infect invest high
growth market basic appli research continu drive growth within
segment
life scienc evp rainer blair highlight driver behind robust hsd core
revenu growth life scienc segment becom increasingli lever
key high growth geographi end market revenu recur natur
china increas sale million dd
revenu growth last three year billion revenu expos
faster-grow biolog end market billion prior acquisit
million genom revenu exposur beckman life scienc
also emphas critic role innov bp segment core
sale growth attribut new product driven product launch well
rapid launch timelin help drive hsd growth note record segment
 spend compound-annual-growth-rate last three year
margin expans remain key focu ebitda margin compar
mid/high teen rate five year ago expand core oper margin
bp driven broad-bas db execut across platform note
visit dhr pall facil westborough continu expect captur
million cost synergi pall target rais million
diagnost revenu
diagnost segment current gener billion revenu repres
estim billion address market adjust ebitda margin
growth healthcar spend high growth market greater invest
prevent predict medicin increas autom continu drive
similar life scienc platform key area focu diagnost platform
includ presenc high growth geographi end-market support core
growth billion exposur china led beckman china
dhr local effort includ center cepheid doubl field
presenc countri help drive dd growth segment across high growth
market expect applic db tool across china high
growth market continu help drive increas market penetr share gain
well facilit strong oper execut china remain lt driver growth
segment manag highlight plan continu invest heavili
within market leverag size scale global footprint increas
exposur faster-grow end market includ molecular test dd annual growth
immunoassay patholog acute/poc msd/hsd
also highlight innov meaning product launch beckman coulter
diagnost hematolog analyz autom test menu addit new digit
workflow solut cepheid cepheid recent product launch includ
genexpert edg clia-waiv xpert xpress test flu flu/rsv strep
expect launch omni poc system albeit delay
note note experienc notabl headwind pama
oner reimburs environ us disconnect recent laboratori
volatil see note lh scoop scottsdal
figur growth diagnost categori oper compani
dental revenu
dental segment current gener billion revenu repres
estim billion market mid-teen adjust ebitda margin north america
note sign end market stabil tradit consum equip
long-term age popul grow middl class increas digit
continu drive end market demand north america china post dd
core revenu compound-annual-growth-rate total dental sinc ampl opportun improv note
per capita dental spend china us china popul
visit dentist least annual
commentari regard outlook dental segment larg line
discuss presid danah dental amir aghdaei credit suiss dental
summit late novemb see note reiter target complet dentalco
spin manag aim replic db playbook
help drive flat/lsd organ growth msd specialti dentalco revenu
also supplement growth opportun note implant system technolog
softwar treatment plan
dental platform post anem core growth last two year
manag expect consist healthier growth experi driven
north american end market stabil improv innov
commerci execut follow two year destock posit sell-out trend
enhanc channel visibl support top-line acceler ahead
separ note encourag earli adopt trend australia spark
clear align system launch june posit feedback doctor note
number case start doubl novemb decemb albeit low base
remind spark approv us associ launch nt event
comprehens review clear align market competit landscap see
slide deck state clear align market
term profit target bp annual oper margin expans longer
term dental benefit recent effici initi sinc
acquisit nobel biocar view entir dental segment new acquisit
leverag db tool expand gross margin bp last three year also
reduc number oper compani three cut manufactur
back offic site establish share platform servic channel
save intern invest increas salesforc
number softwar engin last three year
figur driver futur growth dental flat/ lsd opportun
acceler
detail spin see note assess spinco
environment appli scienc revenu
environment appli scienc segment current gener estim
billion revenu repres billion total address market size
ytd ebitda margin emphas import segment characterist
includ low cyclic high custom sticki driven product
specified/recommend guidanc manual note prefer methodolog
regulatori bodi govern agenc fda epa therebi stimul
steadi demand revenu highli recur natur hach videojet
earn two-to-four time much revenu consum compar applic
importantli manag note environment appli scienc segment led
term digit innov water qualiti digit revenu grow
compound-annual-growth-rate sinc expect digit innov continu water qualiti predict
analyt potenti area focu futur
water qualiti lt growth expect driven increas regul water
scarciti drought infrastructur invest high growth market increas
demand full workflow solut manag highlight effort high growth
market hach franchis post ytd core growth compar
solid msd growth develop market innov offer hach claro
digit workflow softwar help municip manag water qualiti spur
overal msd core growth platform averag last five year
peer lsd high growth market water qualiti post revenu growth
ytd also help intern salesforc invest
product identif key growth driver includ brand consist multi-national
compani consum safeti traceabl particularli pharmaceut industri
chang consum behavior evolv market techniqu repres
estim revenu like water qualiti pid post msd core growth
averag last five year ahead peer driven strength
videojet post msd higher growth consecut quarter
doubl number printer servic contract sinc water qualiti
predict analyt repres import upcom frontier hope data
analyt capabl enabl anticip servic issu custom
proactiv therebi enhanc valu proposit
compani mention price
labcorp america lh
